Consolidated figures
| Ratio | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Margins | |||
| Gross margin % | 29.9% | 32% | 34% |
| EBITDA margin % | 10.3% | 10.8% | 10.2% |
Consolidated figures
| Ratio | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Margins | |||
| Gross margin % | 29.9% | 32% | 34% |
| EBITDA margin % | 10.3% | 10.8% | 10.2% |
| EBIT margin % |
| 6.6% |
| 6.9% |
| 6.4% |
| PAT margin % | 3.4% | 3.9% | 2.1% |
| Working capital | |||
| Receivable days | 86 | 81 | 105 |
| Inventory days | 64 | 43 | 47 |
| Payable days | 170 | 151 | 187 |
| NWC days | -20 | -27 | -35 |
| Leverage | |||
| Current ratio | 1.11 | 1.36 | 1.29 |
| Debt to EBITDA | 1.8 | 1.65 | 2.91 |
| Debt to equity | 0.68 | 0.42 | 0.65 |
| Interest coverage | 2.2 | 2.1 | 1.7 |
| Asset turnover | 0.82 | 0.73 | 0.62 |
| Return ratios | |||
| Return on assets % | 2.8% | 2.8% | 1.3% |
| Return on capital employed % | 19.7% | 17.7% | 12.7% |
| Return on equity % | 12.5% | 9.3% | 4.6% |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.